HomeInvestor DirectoryDNA SequencingMostafa Ronaghi
MR
Mostafa Ronaghi
Executive Board Member & Co-founder at Cellanome · Menlo Park, California, United States
Active now
Check size
Undisclosed
Lead stage
Early
Deals tracked
4
Sectors
DNA Sequencing, Molecular Diagnostics
DNA Sequencing Molecular Diagnostics Systems Biology Live Cell Analysis Biotechnology
United States California

About Mostafa
Mostafa Ronaghi is a Director with expertise in identifying and supporting emerging technology ventures. Limited public information is available regarding his specific firm affiliation, investment stage focus, and sector specialization based on the provided data
Investment thesis
Developing technology to study live cells at scale to understand how cells behave differently in reaction to stimuli
Mostafa Ronaghi is a molecular biologist and technology developer focused on advancing DNA sequencing and live cell analysis. He is an inventor of pyrosequencing methods and best known for his work as Chief Technology Officer at Illumina from 2008 to 2021. His current work at Cellanome aims to help biologists understand cell behavior at scale.
Recent activity
Jun 2026 Filed Form D — Investment vehicle · $75,930,476 raised
Live platform data · proprietary, citable layer
Notable portfolio
Illumina (Chief Technology Officer, 2008-2021) GRAIL Board of Directors Cellanome (Co-founder)

Frequently asked
Does Mostafa Ronaghi invest at early stage?
Yes. They focus on early-stage companies. Their geographic focus includes United States, California.
What is their typical check size?
Check size is not publicly disclosed. They currently invest through Cellanome.
What sectors does Mostafa Ronaghi focus on?
Mostafa Ronaghi primarily invests in DNA Sequencing, Molecular Diagnostics, Systems Biology, Live Cell Analysis.
Are you a fit for Mostafa Ronaghi?
See your match score free · under a minute
Check my fit free